Cargando…

Long term outcome of antiviral therapy in patients with hepatitis B associated decompensated cirrhosis

AIM: To investigate survival rate and incidence of hepatocellular carcinoma (HCC) in patients with decompensated cirrhosis in the antiviral era. METHODS: We used the Korean Health Insurance Review and Assessment. Korea’s health insurance system is a public single-payer system. The study population c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ju, Young-Cheol, Jun, Dae-Won, Choi, Jun, Saeed, Waqar Khalid, Lee, Hyo-Young, Oh, Hyun-Woo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2018
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209577/ https://www.ncbi.nlm.nih.gov/pubmed/30386110 http://dx.doi.org/10.3748/wjg.v24.i40.4606

Ejemplares similares

Safety and efficacy of tenofovir in chronic hepatitis B-related decompensated cirrhosis
por: Lee, Soon Kyu, et al.
Publicado: (2017)

Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals
por: Guardigni, Viola, et al.
Publicado: (2017)

Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis
por: Hayward, Kelly L, et al.
Publicado: (2017)

Elevated calprotectin levels are associated with mortality in patients with acute decompensation of liver cirrhosis
por: Matiollo, Camila, et al.
Publicado: (2022)

Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China
por: Shen, Zi-Xuan, et al.
Publicado: (2022)

Hepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: A prospective cohort study
por: Choi, Gwang Hyeon, et al.
Publicado: (2022)

Differential hepatic features presenting in Wilson disease-associated cirrhosis and hepatitis B-associated cirrhosis
por: Zhong, Hao-Jie, et al.
Publicado: (2019)

Direct-Acting Antivirals for HCV Treatment in Decompensated Liver Cirrhosis Patients: A Systematic Review and Meta-Analysis
por: An, JiHyun, et al.
Publicado: (2022)

Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study
por: Ferrarese, Alberto, et al.
Publicado: (2018)

Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis
por: Rinaldi, Luca, et al.
Publicado: (2017)

Can We Trust Safety of Tenofovir Disoproxil in Patients with Decompensated Cirrhosis?
por: Oh, Hyunwoo, et al.
Publicado: (2017)

Management of betablocked patients after sustained virological response in hepatitis C cirrhosis
por: Abadía, Marta, et al.
Publicado: (2019)

Defining Physiological Decompensation: An Expert Consensus and Retrospective Outcome Validation
por: Mitchell, Oscar J. L., et al.
Publicado: (2022)

A new theory to promote self-management of symptom clusters and healthcare quality in patients with decompensated cirrhosis
por: Liu, Zhen, et al.
Publicado: (2023)

Fatal lactic acidosis in hepatitis B virus-associated decompensated cirrhosis treated with tenofovir: A case report
por: Jung, Tae Yang, et al.
Publicado: (2017)

Changes in characteristics of patients with hepatitis C virus-related cirrhosis from the beginning of the interferon-free era
por: Brzdęk, Michał, et al.
Publicado: (2023)

Effect of treating chronic hepatitis C with direct-acting antivirals on extrahepatic cutaneous manifestations
por: El Kassas, Mohamed, et al.
Publicado: (2020)

Effectiveness and safety of generic and brand direct acting antivirals for treatment of chronic hepatitis C
por: Abdulla, Maheeba, et al.
Publicado: (2022)

Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus
por: Rupp, Christian, et al.
Publicado: (2018)

Assessing significant fibrosis using imaging-based elastography in chronic hepatitis B patients: Pilot study
por: Park, Hee Sun, et al.
Publicado: (2019)

Apolipoprotein E polymorphism influences orthotopic liver transplantation outcomes in patients with hepatitis C virus-induced liver cirrhosis
por: Nascimento, José Carlos Rodrigues, et al.
Publicado: (2021)

Hepatic Venous Pressure Gradient Predicts Long-Term Mortality in Patients with Decompensated Cirrhosis
por: Kim, Tae Yeob, et al.
Publicado: (2016)

Real life efficacy and safety of direct-acting antiviral therapy for treatment of patients infected with hepatitis C virus genotypes 1, 2 and 3 in northwest China
por: Yang, Ying, et al.
Publicado: (2019)

Splenectomy prior to antiviral therapy in patients with hepatitis C virus related decompensated cirrhosis
por: Ji, Fanpu, et al.
Publicado: (2013)

M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals
por: Saleh, Shereen A, et al.
Publicado: (2020)

Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders
por: Dybowska, Dorota, et al.
Publicado: (2023)

Novel markers of endothelial dysfunction in hepatitis C virus-related cirrhosis: More than a mere prediction of esophageal varices
por: Hanafy, Amr Shaaban, et al.
Publicado: (2020)

Gut dysbiosis and body composition in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

Hepatitis C virus eradication with directly acting antivirals improves health-related quality of life and psychological symptoms
por: Nardelli, Silvia, et al.
Publicado: (2019)

Thrombocytopenia in cirrhosis: Impact of fibrinogen on bleeding risk
por: Thakrar, Sonali V, et al.
Publicado: (2017)

Assessment of resting energy expenditure in patients with cirrhosis
por: Ferreira, Shaiane, et al.
Publicado: (2022)

Evaluation of the nutritional status of patients with liver cirrhosis
por: Janota, Barbara, et al.
Publicado: (2023)

Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis
por: De Roza, Marianne Anastasia, et al.
Publicado: (2019)

Diagnostic delay in inflammatory bowel disease increases the risk of intestinal surgery
por: Lee, Dong-won, et al.
Publicado: (2017)

Short-term prognostic factors for hepatitis B virus-related acute-on-chronic liver failure
por: Ye, Qiao-Xia, et al.
Publicado: (2022)

Efficacy and safety of combined directly acting antivirals for treatment of Chinese chronic hepatitis C patients in a real-world setting
por: Chen, Jian-Hong, et al.
Publicado: (2017)

Hospital resource intensity and cirrhosis mortality in United States
por: Mathur, Amit K, et al.
Publicado: (2017)

Efficacy and safety of COVID-19 vaccination in patients with cirrhosis
por: Ivashkin, Vladimir, et al.
Publicado: (2022)

Hepatitis D virus dual-infection among Chinese hepatitis B patient related to hepatitis B surface antigen, hepatitis B virus DNA and age
por: Zi, Jun, et al.
Publicado: (2023)

Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections
por: Sun, Hsin-Yun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_97gsieqm8d4pgfs53u6d2tdqsv